Our News on Newswise

UC Davis total-body advanced PET scanner EXPLORER can visualize dual blood supply in lung cancer

New study shows UC Davis total-body advanced PET scanner EXPLORER can visualize dual blood supply in lungs and effectively evaluate lung cancer and track treatment progress.
10-Jun-2024 3:05 PM EDT Add to Favorites

Treating nephrocalcinosis in newborns: A primer for clinicians

As many as 40% of preterm infants in the U.S. suffer from nephrocalcinosis, a condition that deposits excess calcium in kidneys.
10-Jun-2024 10:30 AM EDT Add to Favorites

Newswise: 6660e5241bf65_OvapreneandHand.png

Hormone-free barrier contraceptive undergoing clinical trial at UC Davis Health

The UC Davis Department of Obstetrics and Gynecology is recruiting potential participants for a clinical trial of an investigational hormone-free monthly intravaginal method of contraception.
6-Jun-2024 10:30 AM EDT Add to Favorites

An anti-inflammatory curbs spread of fungi causing serious blood infections

Study finds that mesalamine, a common anti-inflammatory drug, can fight the fungus Candida albicans in the gut, potentially preventing the risk of invasive candidiasis in patients with blood cancers.
4-Jun-2024 2:05 PM EDT Add to Favorites

Cause of common type of heart failure may differ for women and men

A new mouse study of heart failure with preserved ejection fraction (HFpEF) found sex differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.
30-May-2024 11:05 AM EDT Add to Favorites

Researchers find key differences in brain development between autistic boys and girls

A new study by UC Davis researchers finds key differences in the development of the cortex between autistic boys and girls ages 2-13.
23-May-2024 8:05 PM EDT Add to Favorites

Nightmares and hallucinations could signal autoimmune disease

An increase in nightmares and hallucinations could signal the onset of autoimmune diseases such as lupus, according to a new study.
21-May-2024 6:05 PM EDT Add to Favorites

Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22q

A new UC Davis study finds biomarkers that could identify patients with 22q11.2 deletion syndrome who are more likely to develop schizophrenia.
1-May-2024 5:05 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Florette K. Gray Hazard appointed chair of Pathology and Laboratory Medicine

Florette K. Gray Hazard, a pediatric pathologist, has been appointed chair of the Department of Pathology and Laboratory Sciences at the UC Davis School of Medicine. She will lead a department with 50 faculty, 16 residents, and more than 400...
4-Mar-2024 6:05 PM EST

Are over-the-counter eye drops safe?

Dozens of eye drop recalls this year have left consumers confused about product safety. An expert explains why there have been so many recalls and how to pick safe eye drops.
19-Dec-2023 2:05 PM EST

Kids don't know they need glasses: 7 vision tips for parents

Can your child see the blackboard at school? Ophthalmologist Marcela Maria Estrada explains why kids often don’t know they have bad eyesight and gives tips for healthy vision.
18-Aug-2023 2:35 PM EDT

Anxiety disorders will affect nearly 1 in 3 adults: Here’s what you need to know

A UC Davis expert explains anxiety versus fear and how anxiety disorders can be effectively treated with therapy, medications and self-care.
10-May-2023 6:20 PM EDT

Extreme Risk Protection Orders to Prevent Mass Shootings: What Does the Research Show?

Mass shooters frequently share their plans, creating opportunities to intervene. Experts from the UC Davis Violence Prevention Research Program provide an overview of the research on mass shootings and the “red flag” laws or extreme risk...
24-Jun-2022 9:20 AM EDT

See All Experts

Our YouTube Videos

About

UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 100,000 adults and children every year and access to more than 200 active clinical trials at any given time. Its innovative research program engages more than 240 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists.

Experts

close
0.29871